Chinese Herbal Sachet Therapy for Sleep Quality in Menopausal Women
Effect of Chinese Herbal Sachet Therapy on Improving Sleep Quality of Midlife Women in Macao: A Randomized Placebo-Controlled Trial
1 other identifier
interventional
122
1 country
1
Brief Summary
Many women sleep poorly during the menopausal transition. Some prefer not to take hormone therapy or sleeping tablets, and ask their nurses about other options. This study tested a traditional Chinese medicine aromatic sachet containing ten herbs, chosen by a panel of experts. Women placed the sachet beside their pillow each night for nine weeks and removed it each morning. One hundred and twenty-two women aged 45 to 59 who reported poor sleep and were recruited in Macao took part. Half received the herbal sachet and half received a placebo sachet, which was identical in appearance, weight and packaging and carried a herbal scent, but did not contain the herbs being tested. Participants were not told which sachet they had been given. Sleep quality was measured using the Pittsburgh Sleep Quality Index at the start of the study and again after 3, 6 and 9 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2024
CompletedFirst Submitted
Initial submission to the registry
August 6, 2026
CompletedFirst Posted
Study publicly available on registry
August 11, 2026
CompletedAugust 11, 2026
August 1, 2026
4 months
August 6, 2026
August 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Pittsburgh Sleep Quality Index (PSQI) global score
The Pittsburgh Sleep Quality Index is a 19-item self-report instrument yielding seven component scores summed to a global score ranging from 0 to 21. Higher scores indicate poorer sleep quality.
Baseline, week 3, week 6, week 9
Secondary Outcomes (3)
Proportion of participants with a PSQI global score of 5 or below
Baseline to week 9
Proportion of participants achieving a reduction of at least 3 points in PSQI global score
Baseline to week 9
Sleep Quality Improvement Index (SQII)
Baseline to week 9
Study Arms (2)
TCM aromatic sachet
EXPERIMENTALTen-herb traditional Chinese medicine aromatic sachet, 103 g total, in a non-woven inner bag (12 x 16 cm) inside a breathable linen outer bag (13 x 18 cm). Participants removed the sachet from a sealed plastic bag 15 minutes before bedtime, placed it within 30 cm of the pillow throughout the sleep period, and resealed it in the plastic bag on waking. The sachet was replaced every three weeks, for a total of nine weeks.
Placebo sachet
PLACEBO COMPARATORPlacebo sachet identical to the active sachet in inner and outer bag, packaging, total weight, usage instructions and three-weekly replacement schedule, for a total of nine weeks. It contained Agastache rugosa, Angelica dahurica, Pueraria montana var. lobata, Plantago asiatica, pumice and Hibiscus sabdariffa, selected to give a plausible but non-identical herbal odour.
Interventions
Aromatic sachet containing Albizia flower 12 g, lavender 12 g, Acorus 5 g, rose 12 g, white chrysanthemum 12 g, Atractylodes 12 g, Angelica 12 g, mugwort 12 g, chuanxiong 7 g and cinnamon twig 7 g, 103 g total. Used nightly beside the pillow for nine weeks and replaced every three weeks.
Odour-plausible placebo sachet containing Agastache rugosa, Angelica dahurica, Pueraria montana var. lobata, Plantago asiatica, pumice and Hibiscus sabdariffa, matched to the active sachet in appearance, weight and packaging. Used nightly beside the pillow for nine weeks and replaced every three weeks.
Eligibility Criteria
You may qualify if:
- Aged 45 to 59 years; self-reported sleep disturbance during the menopausal transition with a baseline Pittsburgh Sleep Quality Index global score of at least 5; normal olfactory function; fluent in reading and writing Chinese; able to use a smartphone application for daily adherence logging; provided written informed consent.
You may not qualify if:
- Severe systemic illness such as cancer or renal or hepatic failure; drug-induced insomnia; severe drug allergy history; acute respiratory illness; drug or alcohol dependence; secondary insomnia due to pain; pregnancy or lactation; current use of non-pharmacological sleep interventions such as acupuncture; current or newly initiated hormone replacement therapy, or unstable hypnotic medication use during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Macao Polytechnic University
Macao, Macao, 999078, Macau
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cindy SIN U LEONG, DHSc, MHS, BSN, RN
Macao Polytechnic University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants were not informed whether they received the active or placebo sachet. The research team was aware of group assignment, outcomes were self-reported, and blinding effectiveness was not assessed.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 6, 2026
First Posted
August 11, 2026
Study Start
December 1, 2023
Primary Completion
March 31, 2024
Study Completion
March 31, 2024
Last Updated
August 11, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Participants did not consent to public release of individual participant data, and the ethics approval did not cover open data deposition. De-identified data may be considered on reasonable request to the corresponding author, subject to ethics committee approval.